Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (91-100 of 496) with videos related to

Pageof 50
Sort By:
Joint Bone Spine|April 8, 2014
Biological treatments given in patients with rheumatoid arthritis or ankylosing spondylitis modify HAT/HDAC (histone acetyltransferase/histone deacetylase) balanceEric Toussirot, Daniel Wendling, Georges Herbein, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2009
Management of ankylosing spondylitis with infliximabÉric Toussirot, Ewa Bertolini, Daniel Wendling
Journal of Crohn'S & Colitis|July 24, 2012
The complexity of adverse side-effects to biological agentsFrançois Aubin, Franck Carbonnel, Daniel Wendling
Annals of the Rheumatic Diseases|April 11, 2023
ChatGPT: when artificial intelligence replaces the rheumatologist in medical writingFrank Verhoeven, Daniel Wendling, Clément Prati
Joint Bone Spine|March 13, 2024
Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implicationsPhilippe Goupille, Lucine Vuitton, Daniel Wendling
The Journal of Rheumatology|January 3, 2018
Secondary Calcinosis of the FootMaxime Sondag, Clément Prati, Daniel Wendling
Joint Bone Spine|April 24, 2026
Late-onset psoriatic arthritis: a separate entityDaniel Wendling, Frank Verhoeven, Clément Prati
Expert Opinion on Biological Therapy|March 30, 2026
Biologic therapies for axial c: progress and future challengesDaniel Wendling, Frank Verhœven, Clément Prati
Joint Bone Spine|November 21, 2022
Sonographic aspect of pseudo sarcomatous bone metastasisNicolas Giraud, Maxime Gallet, Daniel Wendling
Expert Opinion on Biological Therapy|December 1, 2018
Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitisDaniel Wendling, Frank Verhoeven, Clément Prati
Pageof 50

Showing results (91-100 of 496) with videos related to

Sort By:
Pageof 50
Joint Bone Spine|April 8, 2014
Biological treatments given in patients with rheumatoid arthritis or ankylosing spondylitis modify HAT/HDAC (histone acetyltransferase/histone deacetylase) balanceEric Toussirot, Daniel Wendling, Georges Herbein, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2009
Management of ankylosing spondylitis with infliximabÉric Toussirot, Ewa Bertolini, Daniel Wendling
Journal of Crohn'S & Colitis|July 24, 2012
The complexity of adverse side-effects to biological agentsFrançois Aubin, Franck Carbonnel, Daniel Wendling
Annals of the Rheumatic Diseases|April 11, 2023
ChatGPT: when artificial intelligence replaces the rheumatologist in medical writingFrank Verhoeven, Daniel Wendling, Clément Prati
Joint Bone Spine|March 13, 2024
Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implicationsPhilippe Goupille, Lucine Vuitton, Daniel Wendling
The Journal of Rheumatology|January 3, 2018
Secondary Calcinosis of the FootMaxime Sondag, Clément Prati, Daniel Wendling
Joint Bone Spine|April 24, 2026
Late-onset psoriatic arthritis: a separate entityDaniel Wendling, Frank Verhoeven, Clément Prati
Expert Opinion on Biological Therapy|March 30, 2026
Biologic therapies for axial c: progress and future challengesDaniel Wendling, Frank Verhœven, Clément Prati
Joint Bone Spine|November 21, 2022
Sonographic aspect of pseudo sarcomatous bone metastasisNicolas Giraud, Maxime Gallet, Daniel Wendling
Expert Opinion on Biological Therapy|December 1, 2018
Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitisDaniel Wendling, Frank Verhoeven, Clément Prati
Pageof 50